Paul Peter Tak, CEO: Candel Therapeutics CADL Sell · Filed 25/01/17

Trade details

Type: Insider sale
Amount: $156,919.92
Shares · price: 21,704 sh · $7.23 a share
Held after: 251,912 sh
Stock: Candel Therapeutics CADL
Person: Paul Peter TakCEO
Trade date: 25/01/15
Filed: 25/01/17
Days to filing: 2 days

Sold 7.9% of holdings

Share of holding sold: 7.9%

Candel Therapeutics trades, last 26 weeks

What else happened in Candel Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/16~25/02/14

Paul Peter Tak's recent trades

Paul Peter TakCEO
Planned sale10b5-1 planCandel Therapeutics
Planned sale10b5-1 plan
Candel Therapeutics
CADL
$3.4M
280,245 sh
$3.4M
Filed 09/10
Traded 09/10
Paul Peter TakCEO
Sell10b5-1 planCandel Therapeutics
Sell10b5-1 plan
Candel Therapeutics
CADL
$226K
25,772 sh
$226K
Filed 25/03/20
Traded 25/03/18
Paul Peter TakCEO
Sell10b5-1 planCandel Therapeutics
Sell10b5-1 plan
Candel Therapeutics
CADL
$3,600
400 sh
$3,600
Filed 25/03/20
Traded 25/03/19
Paul Peter TakCEO
Planned sale10b5-1 planCandel Therapeutics
Planned sale10b5-1 plan
Candel Therapeutics
CADL
$654.4K
74,106 sh
$654.4K
Filed 25/03/18
Traded 25/03/18
Paul Peter TakOfficer, Director
Planned saleCandel Therapeutics
Planned sale
Candel Therapeutics
CADL
$156.6K
19,970 sh
$156.6K
Filed 25/01/15
Traded 25/01/15